Lacosamide Tablet, Film Coated
Product Images NDC 47335-980

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 47335-980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-lacosamide-figure-1 (Spl Lacosamide Figure 1)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' shows seizure reduction percentages in three clinical studies (Study 2, Study 3, Study 4) comparing placebo and Lacosamide doses ranging from 200 mg to 600 mg per day. Bars depict median percent reductions, with higher reductions noted for Lacosamide doses and statistically significant differences versus placebo indicated.*

FDA Label Image

Spl-lacosamide-figure-2 (Spl Lacosamide Figure 2)

A line graph titled 'Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4' showing responder rates (equal to or greater improvement and worsening) on the y-axis and percent of patients on the x-axis. The graph compares placebo and lacosamide at daily doses of 200 mg, 400 mg, and 600 mg, with lines representing each group. The legend identifies sample sizes for placebo (N=359) and lacosamide groups (N=267, 466, 202 respectively).*

FDA Label Image

Spl-lacosamide-label-100mg (Spl Lacosamide Label 100mg)

Lacosamide Tablets, USP 100 mg film-coated tablets packaging label. The label shows an NDC 47335-922-86, indicating a package of 60 tablets. It includes a pharmacist instruction to dispense with the Medication Guide to each patient. The labeler is Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Spl-lacosamide-label-150mg (Spl Lacosamide Label 150mg)

Label for Lacosamide Tablets USP 150 mg film-coated oral tablets, supplied in a container of 60 tablets. The label includes storage instructions, dispensing information, and manufacturer details for Sun Pharmaceutical Industries, Inc. and Sun Pharmaceutical Industries Ltd.*

FDA Label Image

Spl-lacosamide-label-200mg (Spl Lacosamide Label 200mg)

Lacosamide Tablets USP 200 mg film-coated oral tablets packaging label by Sun Pharmaceutical Industries, Inc. The label indicates 60 tablets per container and includes storage instructions, pharmacy dispensing guidance, and manufacturer details from Sun Pharmaceutical Industries Ltd., India. The NDC number is 47335-980-86.*

FDA Label Image

Spl-lacosamide-label-50mg (Spl Lacosamide Label 50mg)

Label for Lacosamide Tablets USP 50 mg oral film-coated tablets. The label indicates the package contains 60 tablets and is distributed by Sun Pharmaceutical Industries, Inc. It is a prescription-only medication with guidance to dispense a Medication Guide to each patient. The label also shows the NDC 47335-918-86 and a barcode.*

FDA Label Image

Spl-lacosamide-structure (Spl Lacosamide Structure)

Chemical structure of lacosamide, a prescription drug active ingredient. The diagram shows the molecule's atom arrangement and bonds representing version used in lacosamide tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.